Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL

NCT01400685 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
B Chronic Lymphocytic Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Bendamustine
DRUG: Rituximab

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]